Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Neurochemistry International|May 22, 2017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's diseaseSimone Lista, Nicola Toschi, Filippo Baldacci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2017
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's diseaseFilippo Baldacci, Nicola Toschi, Simone Lista, et al.
Frontiers in Aging Neuroscience|February 15, 2018
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical ExerciseSimona Daniele, Deborah Pietrobono, Jonathan Fusi, et al.
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional StudySimone Lista, Nicola Toschi, Filippo Baldacci, et al.
Brain Imaging and Behavior|November 6, 2021
Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjectsFilippo Sean Giorgi, Francesco Lombardo, Alessandro Galgani, et al.
Molecular Neurobiology|May 21, 2026
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network AnalysisMartina De Felice, Alessia Pascazio, Rebecca Piccarducci, et al.
Current Alzheimer Research|July 25, 2023
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer's and Dementia with Lewy BodiesAlessandro Galgani, Giovanni Palermo, Francesco Lombardo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ<sub>1-42</sub>, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40Harald Hampel, Nicola Toschi, Filippo Baldacci, et al.
Journal of Neurochemistry|August 11, 2022
Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuumAlessandro Galgani, Andrea Vergallo, Nicole Campese, et al.
Neuropharmacology|May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discoveryHarald Hampel, Andrea Vergallo, Filippo Caraci, et al.
Pageof 9